Eris Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has submitted a routine compliance certificate for the quarter ended 31st December 2025. The certificate was issued by its Registrar and Share Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited). It confirms that all share dematerialisation requests received from depository participants during the quarter were processed and confirmed to the depositories within the required timelines. The physical share certificates received were mutilated and cancelled, and the depositories' names have been recorded as the registered owners in the company's register of members. This is a standard quarterly regulatory filing with no business or financial details disclosed.
No impact on shareholders or stock price — this is a purely procedural compliance filing required every quarter to confirm that share dematerialisation activities are running smoothly.